Cyprus/Greece/MaltaCyprusGreeceMalta

Athens expands national ban on GM maize varieties

16.05.2007

Athens – Greek Deputy Agriculture Minister Alexandros Kontos has renewed a decree banning the sale of genetically engineered Mon810 Bt maize varieties for another 18 months after an ultimatum of the European Commission ran out in January. In mid-April, his ministry extended this market ban to additional 16 transgenic maize varieties that entered the Common ‘EU Seed Catalogue of Varieties of Agricultural Plant Species’ last year.
Greece fears negative long-term ecological effects such as the development of insect resistance, the disruption of biodiversity among non-harmful and beneficial insects, and a heightened danger of GM cross-pollination due to “the high prevalence of bee-keeping in Greece and the relatively small size of holdings”. The Greek move is based on the so-called safeguard clause, that allows EU member states to implement precautionary measures if they provide scientific evidence for adverse effects on human and animal health or on the environment caused by transgenic crops.
Last summer, the European Food Safety Authority (EFSA) evaluated scientific data presented by the Greek government. However, the EFSA concluded that there was no evidence for any negative impact of the transgenic crops that could justify a national ban on Mon810 acreage. On the basis of this safety assessment, the Commission asked Greece to lift the ban on acreage of the 17 authorized Mon810 varieties.
The Commission is under pressure to push the member states to follow the EU decisions on GM varieties. Otherwise it has to face financial consequences due to market protectionism. In 2006, the World Trade Organisation (WTO) concluded that there was no scientific evidence for a EU GM moratorium from 1998 to 2003 and demanded the Commission lift the existing GM market bans.
The GM-sceptical environmental group Greenpeace applauded Greece’s decision to renew and to extend its ban on the sale and cultivation of genetically-modified maize seeds.

Cyprus/Greece/MaltaCyprusGreeceMalta

06.03.2005

Athens - A three-day conference covering all issues of biotechnology at both fundamental and application level will be held in July this year in Athens: “2nd International Greek Biotechnology Forum - IGBF2”. The event aims at...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Athens - The Greek agriculture minister recently announced that the country will destroy over 9,000 acres of fields planted with biotech-mixed cotton. The Greek government will pay affected farmers an estimated Euro4 million....

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2005

Heraklion/Paris - Together with French Vaxon-Biotech S.A. the Herak-lion University Hospital in Crete has completed the phase I trial of Vaxon's candidate vaccine VX-001, which contains a single optimized cryptic peptide that...

Cyprus/Greece/MaltaCyprusGreeceMalta

13.11.2004

Athens - The Hellenic Innovation Centre presented a new technology in October that enables the production of high-grade pharmaceutical raw material like Inter-feron- and - , Erythropoietin, FSH, and HGH, without unwanted...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.10.2004

Heraklion - The recent research advances on lymphocytes, the most sophisticated of all mature hematopoietic cell types, will be presented during the 2nd Gene Regulation in Lymphocyte Develop-ment Workshop to be held on October...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Valetta - Further to the launch of its DNA Forensics division in February 2004, Synergene Profiling, a subsidiary of the Synergene Biotechnology Group, has successfully completed its first DNA forensic cases.Contracted on behalf...

Cyprus/Greece/MaltaCyprusGreeceMalta

08.05.2004

Athens - The Helenic Society for the Study and Applications of Growth Hormones will hold the 2nd International Congress on Adult Consequences of Childhood Endocrine Diseases from May 6-8 in Athens. Main topics are going to be the...

Cyprus/Greece/MaltaCyprusGreeceMalta

09.04.2004

Attard - The international network Gendia has recently developed a new fast pre-natal test for the most common aneuploidies by quantitative fluorescent PCR (QF-PCR). Gendia was founded last year by the Malta-based biotech company...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.03.2004

Rhodos - SEED ECOLOGY 2004, the first thematic, scientific conference devoted exclusively to seeds and the environment, will take place in Rhodos (April 25 to May 1). The scientific program will cover all aspects of seed eco-logy...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Athens - Biovista recently announced he licensing of its Journal Research AnalystTM (JRA) market intelligence tool by Upstate, Chalottesville/USA, one of the leading suppliers of cell signaling reagents and kinase screening...

Displaying results 31 to 40 out of 47

< Previous 31-40 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/3/article/athens-expands-national-ban-on-gm-maize-varieties.html

Events

All Events

Stock list

All quotes

TOP

  • ADDEX3.13 CHF4.68%
  • CO.DON3.15 EUR4.30%
  • BB BIOTECH146.25 EUR2.17%

FLOP

  • WILEX2.35 EUR-5.24%
  • SANTHERA89.15 CHF-3.10%
  • EVOTEC2.93 EUR-2.33%

TOP

  • CO.DON3.15 EUR26.0%
  • PAION3.01 EUR25.4%
  • SANTHERA89.15 CHF18.9%

FLOP

  • ADDEX3.13 CHF-21.7%
  • EVOTEC2.93 EUR-20.2%
  • MEDIGENE3.95 EUR-14.1%

TOP

  • SANTHERA89.15 CHF2085.0%
  • CO.DON3.15 EUR258.0%
  • PAION3.01 EUR198.0%

FLOP

  • CYTOS0.24 CHF-94.0%
  • MERCK KGAA67.67 EUR-40.4%
  • BIOFRONTERA2.18 EUR-40.3%

No liability assumed, Date: 18.09.2014


Current issue

All issues

Product of the week

Products